7Baggers

AbbVie Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Revenue  
 Gross Profit  
 Net Income  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 -0.022.184.396.68.811.0113.2215.42Billion

AbbVie Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-09-30 2015-06-30 2014-09-30 2014-06-30 2014-03-31 2013-06-30 2013-03-31 
                                               
  net revenues15,423,000,000 13,343,000,000 15,102,000,000 14,460,000,000 14,462,000,000 12,310,000,000 14,301,000,000 13,927,000,000 13,865,000,000 12,225,000,000 15,121,000,000 14,812,000,000 14,583,000,000 13,538,000,000 14,886,000,000 14,342,000,000 13,959,000,000 13,010,000,000 13,858,000,000 12,902,000,000 10,425,000,000 8,619,000,000 8,704,000,000 8,479,000,000 8,255,000,000 7,828,000,000 8,305,000,000 8,236,000,000 8,278,000,000 7,934,000,000 7,739,000,000 6,995,000,000 6,944,000,000 6,538,000,000 6,796,000,000 6,432,000,000 6,452,000,000 5,958,000,000 5,944,000,000 5,475,000,000      
  yoy6.65% 8.39% 5.60% 3.83% 4.31% 0.70% -5.42% -5.97% -4.92% -9.70% 1.58% 3.28% 4.47% 4.06% 7.42% 11.16% 33.90% 50.95% 59.21% 52.16% 26.29% 10.10% 4.80% 2.95% -0.28% -1.34% 7.31% 17.74% 19.21% 21.35% 13.88% 8.75% 7.63% 9.73% 14.33% 17.48%          
  qoq15.59% -11.65% 4.44% -0.01% 17.48% -13.92% 2.69% 0.45% 13.42% -19.15% 2.09% 1.57% 7.72% -9.06% 3.79% 2.74% 7.29% -6.12% 7.41% 23.76% 20.95% -0.98% 2.65% 2.71% 5.45% -5.74% 0.84% -0.51% 4.34% 2.52% 10.64% 0.73% 6.21% -3.80% 5.66% -0.31% 8.29% 0.24% 8.57%       
  cost of products sold4,346,000,000 4,002,000,000 4,396,000,000 4,212,000,000 4,202,000,000 4,094,000,000 5,704,000,000 6,485,000,000 4,240,000,000 3,986,000,000 4,170,000,000 5,022,000,000 4,170,000,000 4,052,000,000 4,320,000,000 4,390,000,000 4,523,000,000 4,213,000,000 4,684,000,000 5,050,000,000 3,711,000,000 1,942,000,000 2,006,000,000 1,920,000,000 1,819,000,000 1,694,000,000 2,022,000,000 1,835,000,000 1,934,000,000 1,927,000,000 2,280,000,000 1,616,000,000 1,528,000,000 1,616,000,000 1,555,000,000 1,504,000,000 1,405,000,000 1,369,000,000 1,167,000,000 916,000,000 1,094,000,000 1,113,000,000 1,100,000,000 1,054,000,000 1,153,000,000 
  gross profit11,077,000,000 9,341,000,000 10,706,000,000 10,248,000,000 10,260,000,000 8,216,000,000 8,597,000,000 7,442,000,000 9,625,000,000 8,239,000,000 10,951,000,000 9,790,000,000 10,413,000,000 9,486,000,000 10,566,000,000 9,952,000,000 9,436,000,000 8,797,000,000 9,174,000,000 7,852,000,000 6,714,000,000 6,677,000,000 6,698,000,000 6,559,000,000 6,436,000,000 6,134,000,000 6,283,000,000 6,401,000,000 6,344,000,000 6,007,000,000 5,459,000,000 5,379,000,000 5,416,000,000 4,922,000,000 5,241,000,000 4,928,000,000 5,047,000,000 4,589,000,000 4,777,000,000 4,559,000,000      
  yoy7.96% 13.69% 24.53% 37.70% 6.60% -0.28% -21.50% -23.98% -7.57% -13.15% 3.64% -1.63% 10.35% 7.83% 15.17% 26.74% 40.54% 31.75% 36.97% 19.71% 4.32% 8.85% 6.61% 2.47% 1.45% 2.11% 15.09% 19.00% 17.13% 22.04% 4.16% 9.15% 7.31% 7.26% 9.71% 8.09%          
  qoq18.58% -12.75% 4.47% -0.12% 24.88% -4.43% 15.52% -22.68% 16.82% -24.76% 11.86% -5.98% 9.77% -10.22% 6.17% 5.47% 7.26% -4.11% 16.84% 16.95% 0.55% -0.31% 2.12% 1.91% 4.92% -2.37% -1.84% 0.90% 5.61% 10.04% 1.49% -0.68% 10.04% -6.09% 6.35% -2.36% 9.98% -3.94% 4.78%       
  gross margin %71.82% 70.01% 70.89% 70.87% 70.94% 66.74% 60.11% 53.44% 69.42% 67.39% 72.42% 66.10% 71.41% 70.07% 70.98% 69.39% 67.60% 67.62% 66.20% 60.86% 64.40% 77.47% 76.95% 77.36% 77.96% 78.36% 75.65% 77.72% 76.64% 75.71% 70.54% 76.90% 78.00% 75.28% 77.12% 76.62% 78.22% 77.02% 80.37% 83.27%      
  selling, general and administrative3,253,000,000 3,293,000,000 3,855,000,000 4,205,000,000 3,377,000,000 3,315,000,000 3,193,000,000 3,372,000,000 3,268,000,000 3,039,000,000 3,417,000,000 3,304,000,000 5,412,000,000 3,127,000,000 3,260,000,000 3,083,000,000 3,164,000,000 2,842,000,000 3,231,000,000 2,846,000,000 3,527,000,000 1,695,000,000 1,951,000,000 1,657,000,000 1,654,000,000 1,680,000,000 1,929,000,000 1,919,000,000 1,760,000,000 1,791,000,000 1,951,000,000 1,452,000,000 1,504,000,000 1,368,000,000 1,653,000,000 1,381,000,000 1,466,000,000 1,355,000,000 1,474,000,000 1,703,000,000 1,595,000,000 1,448,000,000 1,340,000,000 1,406,000,000 1,237,000,000 
  research and development2,131,000,000 2,067,000,000 6,774,000,000 2,130,000,000 1,948,000,000 1,939,000,000 1,927,000,000 1,723,000,000 1,733,000,000 2,292,000,000 1,790,000,000 1,614,000,000 1,609,000,000 1,497,000,000 1,827,000,000 1,673,000,000 1,802,000,000 1,782,000,000 1,890,000,000 1,706,000,000 1,582,000,000 1,379,000,000 1,542,000,000 2,285,000,000 1,291,000,000 1,289,000,000 6,495,000,000 1,268,000,000 1,322,000,000 1,244,000,000 1,402,000,000 1,222,000,000 1,223,000,000 1,135,000,000 1,190,000,000 1,106,000,000 1,124,000,000 946,000,000 1,418,000,000 981,000,000 812,000,000 834,000,000 772,000,000 709,000,000 634,000,000 
  acquired ipr&d and milestones823,000,000 248,000,000 1,574,000,000 82,000,000 937,000,000 164,000,000 282,000,000 66,000,000 280,000,000 150,000,000 243,000,000 40,000,000 269,000,000 145,000,000                                
  other operating income-24,000,000        -169,000,000 -10,000,000   -172,000,000    -68,000,000                             
  total operating costs and expenses10,529,000,000 9,610,000,000 16,592,000,000 10,629,000,000 10,464,000,000 9,512,000,000 11,106,000,000 11,646,000,000 9,352,000,000 9,457,000,000 9,619,000,000 10,209,000,000 11,288,000,000 8,821,000,000 9,812,000,000 10,036,000,000 9,518,000,000 8,907,000,000 10,105,000,000 9,647,000,000 9,673,000,000 5,016,000,000 4,748,000,000 5,862,000,000 4,855,000,000 4,818,000,000 10,746,000,000 5,077,000,000 5,516,000,000 5,031,000,000 5,945,000,000 4,290,000,000 4,270,000,000 4,119,000,000 4,438,000,000 4,071,000,000 4,065,000,000 3,680,000,000 4,059,000,000 3,623,000,000 4,059,000,000 3,411,000,000 3,212,000,000 3,239,000,000 3,024,000,000 
  operating earnings4,894,000,000 3,733,000,000 -1,490,000,000 3,831,000,000 3,998,000,000 2,798,000,000 3,195,000,000 2,281,000,000 4,513,000,000 2,768,000,000 5,502,000,000 4,603,000,000 3,295,000,000 4,717,000,000 5,074,000,000 4,306,000,000 4,441,000,000 4,103,000,000 3,753,000,000 3,255,000,000 752,000,000 3,603,000,000 3,956,000,000 2,617,000,000 3,400,000,000 3,010,000,000 -2,441,000,000 3,159,000,000 2,762,000,000 2,903,000,000 1,794,000,000 2,705,000,000 2,674,000,000 2,419,000,000 2,358,000,000 2,361,000,000 2,387,000,000 2,278,000,000 1,885,000,000 1,852,000,000 960,000,000 1,515,000,000 1,351,000,000 1,453,000,000 1,305,000,000 
  interest expense678,000,000 627,000,000 610,000,000 591,000,000 506,000,000 453,000,000 378,000,000 398,000,000 454,000,000 454,000,000 476,000,000 497,000,000 532,000,000 539,000,000 571,000,000 585,000,000 606,000,000 622,000,000 618,000,000 620,000,000 614,000,000 428,000,000 455,000,000 420,000,000 309,000,000 325,000,000 319,000,000 302,000,000 272,000,000 251,000,000 252,000,000 252,000,000 253,000,000 247,000,000 290,000,000 250,000,000 225,000,000 200,000,000 197,000,000 164,000,000 128,000,000 69,000,000 65,000,000   
  net foreign exchange loss23,000,000 4,000,000   1,000,000 4,000,000 49,000,000 25,000,000 37,000,000 35,000,000 40,000,000 36,000,000 47,000,000 25,000,000 16,000,000 12,000,000 14,000,000 9,000,000 17,000,000 20,000,000 29,000,000 5,000,000 11,000,000 19,000,000 6,000,000 6,000,000 6,000,000 2,000,000 8,000,000 8,000,000   6,000,000 13,000,000   15,000,000 302,000,000 13,000,000 14,000,000 174,000,000 5,000,000 3,000,000 14,000,000 15,000,000 
  other income2,639,000,000 1,441,000,000 150,000,000 1,159,000,000 1,345,000,000 586,000,000 1,556,000,000 -95,000,000 1,412,000,000 1,804,000,000 2,021,000,000 -330,000,000 1,533,000,000 -776,000,000 216,000,000 21,000,000 2,658,000,000 -395,000,000 4,625,000,000 115,000,000 802,000,000 72,000,000    135,000,000   500,000,000 -153,000,000 29,000,000 349,000,000 62,000,000 73,000,000 38,000,000 101,000,000     250,000,000 8,000,000    
  earnings before income tax expense1,554,000,000 1,661,000,000 -2,269,000,000 2,084,000,000 2,146,000,000 1,755,000,000 1,212,000,000 1,953,000,000 2,610,000,000 475,000,000 2,965,000,000 4,400,000,000 1,183,000,000 4,929,000,000 4,271,000,000 3,688,000,000 1,163,000,000 3,867,000,000 -1,507,000,000 2,500,000,000 -693,000,000 3,098,000,000 1,338,000,000 2,001,000,000 807,000,000 2,544,000,000 1,892,500,000 2,761,000,000 2,012,000,000 2,797,000,000 1,193,000,000 2,095,000,000 2,353,000,000 2,086,000,000 1,998,000,000 2,014,000,000 2,096,000,000 1,776,000,000 1,647,000,000 1,678,000,000 687,000,000 1,433,000,000 1,286,000,000 1,368,000,000 1,239,000,000 
  income tax expense613,000,000 372,000,000 419,000,000 520,000,000 773,000,000 383,000,000 388,000,000 172,000,000 583,000,000 234,000,000 284,750,000 448,000,000 255,000,000 436,000,000 303,500,000 508,000,000 394,000,000 312,000,000 80,250,000 187,000,000 46,000,000 88,000,000 67,750,000 117,000,000 66,000,000 88,000,000 14,250,000 14,000,000 29,000,000 14,000,000 1,141,000,000 464,000,000 438,000,000 375,000,000 607,000,000 416,000,000 486,000,000 422,000,000 408,000,000 312,000,000 181,000,000 335,000,000 306,000,000 300,000,000 271,000,000 
  net earnings941,000,000 1,289,000,000 -23,000,000 1,564,000,000 1,373,000,000 1,372,000,000 824,000,000 1,781,000,000 2,027,000,000 241,000,000 2,472,000,000 3,952,000,000 928,000,000 4,493,000,000 4,045,000,000 3,180,000,000 769,000,000 3,555,000,000 38,000,000 2,313,000,000 -739,000,000 3,010,000,000 2,801,000,000 1,884,000,000 741,000,000 2,456,000,000 -1,826,000,000 2,747,000,000 1,983,000,000 2,783,000,000 52,000,000 1,631,000,000 1,915,000,000 1,711,000,000 1,391,000,000 1,598,000,000 1,610,000,000 1,354,000,000 1,239,000,000 1,366,000,000 506,000,000 1,098,000,000 980,000,000 1,068,000,000 968,000,000 
  net earnings attributable to noncontrolling interest3,000,000 3,000,000 -1,000,000 3,000,000 3,000,000 3,000,000 2,000,000 3,000,000 3,000,000 2,000,000 -1,000,000 3,000,000 4,000,000 3,000,000 1,000,000 1,000,000 3,000,000 2,000,000 2,000,000 5,000,000                          
  net earnings attributable to abbvie inc.938,000,000 1,286,000,000 -22,000,000 1,561,000,000 1,370,000,000 1,369,000,000 822,000,000 1,778,000,000 2,024,000,000 239,000,000 2,473,000,000 3,949,000,000 924,000,000 4,490,000,000 4,044,000,000 3,179,000,000 766,000,000 3,553,000,000 36,000,000 2,308,000,000 -738,000,000                         
  yoy-31.53% -6.06% -102.68% -12.20% -32.31% 472.80% -66.76% -54.98% 119.05% -94.68% -38.85% 24.22% 20.63% 26.37% 11133.33% 37.74% -203.79%                             
  qoq-27.06% -5945.45% -101.41% 13.94% 0.07% 66.55% -53.77% -12.15% 746.86% -90.34% -37.38% 327.38% -79.42% 11.03% 27.21% 315.01% -78.44% 9769.44% -98.44% -412.74%                          
  net income margin %6.08% 9.64% -0.15% 10.80% 9.47% 11.12% 5.75% 12.77% 14.60% 1.96% 16.35% 26.66% 6.34% 33.17% 27.17% 22.17% 5.49% 27.31% 0.26% 17.89% -7.08% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%      
  per share data                                             
  basic earnings per share attributable to abbvie inc.0.52 0.72 -0.01 0.88 0.77 0.77 0.46 1.14 0.13 1.39 2.22 0.52 2.52 2.27 1.78 0.42 -0.05 1.3 -0.46                         
  diluted earnings per share attributable to abbvie inc.0.52 0.72 -0.02 0.88 0.77 0.77 0.46 1.14 0.13 1.39 2.21 0.51 2.51 2.26 1.78 0.42 1.99 -0.05 1.29 -0.46                         
  weighted-average basic shares outstanding1,768 1,768 1,769 1,769 1,768 1,769 1,768 1,767 1,767 1,770 1,771 1,771 1,770 1,771 1,770 1,770 1,769 1,769 1,667 1,769 1,647 1,481 1,481 1,481 1,480 1,480 1,541 1,511 1,568 1,591 1,596 1,597 1,595 1,597 1,622 1,632 1,624 1,616 1,652 1,620 1,595 1,594 1,595 1,589 1,588 
  weighted-average diluted shares outstanding1,771 1,772 1,773 1,772 1,771 1,773 1,773 1,771 1,771 1,776 1,778 1,776 1,776 1,778 1,777 1,777 1,776 1,775 1,673 1,774 1,647 1,484 1,484 1,483 1,484 1,483 1,546 1,515 1,572 1,596 1,603 1,603 1,600 1,603 1,631 1,640 1,632 1,625 1,664 1,633 1,610 1,608 1,609 1,609 1,605 
  net foreign exchange gain  500,000 -3,000,000                           7,000,000 9,000,000   78,250,000 -4,000,000          
  other operating expense          -1,000,000 229,000,000   108,000,000 500,000,000                              
  acquired in-process research and development              405,000,000 390,000,000 97,000,000 70,000,000 300,000,000 45,000,000 853,000,000  139,000,000  91,000,000 155,000,000 300,000,000 55,000,000  69,000,000 312,000,000  15,000,000  40,000,000 80,000,000 70,000,000 10,000,000  23,000,000 308,000,000 16,000,000  70,000,000  
  net income attributable to noncontrolling interest                    -1,000,000                         
  basic earnings per share                     2.02 1.89 1.27 0.49 1.65 -1.14 1.81 1.26 1.74 0.03 1.02 1.2 1.07 0.86 0.97 0.99 0.83 0.75 0.84 0.32 0.69 0.61 0.67 0.61 
  diluted earnings per share                     2.02 1.87 1.26 0.49 1.65 -1.13 1.81 1.26 1.74 0.03 1.01 1.19 1.06 0.85 0.97 0.98 0.83 0.74 0.83 0.31 0.68 0.61 0.66 0.6 
  cash dividends declared per common share                            0.96 0.96 0.71 0.64 0.64 0.64 0.64 0.57 0.57 0.57 0.51 0.51 0.42 0.42 0.42 0.4 0.8 
  other income (income)                                    51,000,000  28,000,000       
  net sales                                        5,019,000,000 4,926,000,000 4,563,000,000 4,692,000,000 4,329,000,000 
  interest income                                           75,000,000 66,000,000 

We provide you with 20 years income statements for AbbVie stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of AbbVie stock. Explore the full financial landscape of AbbVie stock with our expertly curated income statements.

The information provided in this report about AbbVie stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.